3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
13
Carcinoma, Non-Small-Cell Lung
11
Neoplasm Metastasis
7
Brain Neoplasms
7
Rectal Neoplasms
6
Lung Neoplasms
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Prostatic Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Uterine Cervical Neoplasms
3
Pancreatic Neoplasms
3
Melanoma
3
Glioblastoma
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Inflammatory Breast Neoplasms
2
Glioma
2
Central Nervous System Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Adenocarcinoma
2
Vaginal Neoplasms
1
Interventions
Letrozole
5
Paclitaxel
4
atamestane
3
Toremifene
3
Tamoxifen
3
Cyclophosphamide
3
Estrogen Receptor Modulators
2
Epirubicin
2
Doxorubicin
2
Docetaxel
2
Carboplatin
2
Capecitabine
2
Aromatase Inhibitors
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
pertuzumab
1
ferric carboxymaltose
1
atezolizumab
1
Vinorelbine
1
Trastuzumab
1
TP protocol
1
Surgical Procedures, Operative
1
Radiotherapy
1
Medroxyprogesterone
1
Fulvestrant
1
Fluorouracil
1
Estrogens, Conjugated (USP)
1
Cisplatin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Ductal, Breast
×
Surgical Procedures, Operative
×
Clear all
NCT02620280
2024-03-06
NeoTRIPaPDL1
Fondazione Michelangelo
Phase 3
Completed
278 enrolled